Barclays Maintains Overweight on Waters, Raises Price Target to $500
10/7/2026
Impact: 70
Healthcare
Barclays analyst Luke Sergott has maintained an Overweight rating on Waters (NYSE: WAT) and increased the price target from $460 to $500. This adjustment reflects a positive outlook for the company in the market.
AI summary, not financial advice
Share: